Welcome to the TCT Connect Press Room!
The Cardiovascular Research Foundation (CRF) is committed to keeping healthcare professionals and the public informed of the latest research news in interventional cardiovascular medicine. On behalf of the TCT media relations team, we look forward to working with you during TCT Connect. You will be able to access all press materials for TCT Connect on this website.
Media, investigators, organizations issuing press releases, and others with access to research accepted for presentation during TCT are required to abide by the embargo policies governing the TCT scientific symposium.
The Cardiovascular Research Foundation (CRF) embargoes information presented as a late-breaking clinical trial or late-breaking science. Coverage of these studies is strictly prohibited until the start time of each trial’s official Main Arena channel presentation as listed in the TCT Connect Program on the official TCT website. No journalist, exhibitor, or university (or affiliated organization or company) may disseminate information until the trial’s official Main Arena presentation time. All embargo times are listed in Eastern Time (ET).
Please note: TCT officially begins on Wednesday, October 14, 2020 at 7:00 AM ET. There are no strict embargoes for research presented as high-impact clinical research, oral abstracts, or poster abstracts, but we recommend you wait until the official start of TCT to file your stories.
Violation of TCT embargo policies can result in removal of the research from the scientific program, removal of individuals and/or companies from the meeting, and revocation of media credentials.
By accepting a media registration for TCT Connect or accepting TCT embargoed materials through email, fax, regular mail, thumb drive, or embargoed press room website, journalists acknowledge the embargoed information is for their use in preparing media coverage and they will not distribute or publish the information while the embargo is in effect. The embargo policy also applies to news releases and other communications from outside organizations that include embargoed information scheduled for presentation at TCT.
Recording (Audio, Video, and Still Photography) and Social Media
CRF promotes the free exchange and rapid dissemination of educational content from our meetings. The slides from CRF-sponsored courses and symposia are immediately posted on TCTMD.com to facilitate scientific discourse and enhance patient care.
Communicating through social media, including posting brief audio and video clips, is strongly encouraged, provided that embargo rules for late-breaking clinical trials and science are honored. However, posting or livestreaming entire sessions or live cases or the use of any CRF course content for commercial purposes, is strictly prohibited (out of respect for patient privacy with regards to live cases).
In order to photograph or record video for the purpose of news coverage, members of the media must obtain written approval from CRF before filming, recording, or taking photographs. Please note that even once approval to film and/or photograph is obtained, filming, videotaping, and photography are limited to agreed-upon terms.
Slides are provided to the media to assist in the development of original news coverage only and not for copying, sale or redistribution. Please note that publishing or posting press conference slides, abstracts, posters or substantial portions of these materials is not permitted.